AP NEWS

Global Molecular Biology Enzymes, Kits and Reagents Market (2018-2023): Analysis by Product, Application, End-User and Geography - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “Global Molecular Biology Enzymes, Kits, and Reagents Market - Segmented by Product (Kits and Enzymes), by Application, by End-User and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The Molecular Biology Enzymes, Kits, and Reagents Market is expected to register a growth rate of 15.4%, over the forecast period.

The rate of growth in R&D funding since 2015 and the location where the growth is centered are both significant. However, the trends suggest a return to growth, with only minor caution, across most areas of R&D spending. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors.As per the 2016 Global R&D funding forecast, this year sponsored by the Industrial Research Institute (IRI), Washington, D.C., revealed that global R&D investments is likely to increase by 3.5% in 2016 to a total of $1.948 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus increased research and R&D investments in the life science industry are augmenting the growth of the market.

In addition, a growing number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

HighlightsHigh Costs and Limited Reimbursements for Genetic Testing is Hindering Growth Asia-Pacific is Expected to Provide Large Growth Opportunities Over the Forecast Period

Key Developments in the Market

Illumina Acquired Edico Genome to accelerate genomic data analysis.Illumina launched iSeq 100 sequencing system.Companies ProfiledAgilent TechnologiesF. Hoffmann-La Roche Ltd.Illumina Inc.Lucigen CorporationMerck KGaANew England Biolabs Inc.Promega CorporationQiagen N.V.Takara Bio Inc.Thermo Fisher Scientific Inc.

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Company Profiles and Competitive Landscape

9. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/2vvl6k/global_molecular?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005221/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Enzymes

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 08:36 AM/DISC: 10/12/2018 08:36 AM

http://www.businesswire.com/news/home/20181012005221/en

AP RADIO
Update hourly